Biotech | January 10, 2022
Novavax and Serum file EUA for Covovax in South Africa
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
It is a recombinant nanoparticle protein-based vaccine
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
